Citigroup’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,694
Closed -$13K 6467
2022
Q2
$13K Buy
11,694
+10,339
+763% +$8.87K ﹤0.01% 5252
2022
Q1
$2K Sell
1,355
-3,548
-72% -$7.59K ﹤0.01% 6110
2021
Q4
$17K Buy
4,903
+2,448
+100% +$13.8K ﹤0.01% 5439
2021
Q3
$22K Buy
2,455
+1,501
+157% +$19.7K ﹤0.01% 5209
2021
Q2
$16K Sell
954
-89
-9% -$1.3K ﹤0.01% 5442
2021
Q1
$14K Sell
1,043
-1,157
-53% -$26K ﹤0.01% 5460
2020
Q4
$63K Buy
2,200
+1,728
+366% +$46.8K ﹤0.01% 5886
2020
Q3
$14K Buy
+472
New +$14.3K ﹤0.01% 6430

Other funds holding AFIB

Citigroup's AFIB Position: Q3 2022 in Review

Citigroup sold out of Acutus Medical Inc (AFIB) in Q3 2022, closing a stake of 11,694 shares — an estimated $13K sold.

Citigroup first reported a position in AFIB in Q3 2020 and held it in 8 quarters. The position peaked at $63K in Q4 2020. 37 funds tracked by Wall St. Rank hold AFIB as of Q3 2022.

  • Citigroup reported no remaining Acutus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 11,694 Acutus Medical Inc shares in Q3 2022, an estimated $13K.
  • Citigroup first reported a position in Acutus Medical Inc in Q3 2020 and held it in 8 quarters.
  • Citigroup's Acutus Medical Inc position peaked at $63K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.